EPCAM and cancer: In a similarly designed study, AdnaTest, which identifies CTCs based on reverse transcriptase-PCR (RT-PCR) amplification of cancer-specific markers such as EGFR, CEA, and EpCAM, demonstrated increased sensitivity when compared with CellSearch® [50,52].